02.04.2013
- India's top court dismissed Swiss drugmaker Novartis's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive...
29.03.2013
- The United States is striving to find an appropriate balance in Asia-Pacific free trade talks between providing strong patent and data protections for U.S. drug manufacturers and...
27.03.2013
- Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week that could have broad consequences for their...
25.03.2013
- AstraZeneca has seen off a remaining threat to its top-selling cholesterol drug Crestor by settling a U.S. legal case with Watson Laboratories, a unit of Actavis, and Egis. The...
25.03.2013
- Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...
23.03.2013
- The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...
05.03.2013
- Par Pharmaceutical has agreed to pay $45 million to settle federal criminal and civil probes over its marketing and sale of a drug to treat appetite loss in AIDS patients, a...
05.03.2013
- Cheaper generic drugs in 2012 brought down spending on treatments for common diseases like high cholesterol for the first time in 20 years, according to a report from the largest...
